Highlights• FY08 result ahead of EBITDA guidance• Underlying...

Highlights
• FY08 result ahead of EBITDA guidance
• Underlying earnings per share accretion
• $463 million iSOFT acquisition and integration completed
• Integration synergies in excess of $27 million from FY09
• Revenue base transformed
o Annualised group revenues - $472 million
o Over 80% of group revenues are now sourced from operations outside of Australia and
South East Asia.
o Over 80% of FYO9 revenues are recurring, contracted or expected.
• Global launch of LORENZO in FY09
• Outlook guidance of 18% revenue growth on the annualised revenue base
IBA Health Group has recorded revenues of $361 million, up 381% (FY07 $75 million), and an underlying
EBITDA of $106 million, up 232% (FY07 $32 million), reflecting the eight-month contribution from iSOFT
which was acquired in November 2007.
The reported NPAT of $14.4 million includes significant items of $35 million (comprising amortisation of
intangibles on acquisition, integration and one-off acquisition costs and impairment charges), making an
underlying NPAT of $49 million, up 113% (FY07 $23 million) against FY07.